Freeze-dried and GMP-compliant pharmaceuticals containing exosomes for acellular mesenchymal stromal cell immunomodulant therapy

被引:109
作者
Bari, Elia [1 ]
Perteghella, Sara [1 ,2 ]
Catenacci, Laura [1 ]
Sorlini, Marzio [2 ,3 ]
Croce, Stefania [4 ]
Mantelli, Melissa [5 ]
Avanzini, Maria A. [5 ]
Sorrenti, Milena [1 ]
Torre, Maria L. [1 ,2 ]
机构
[1] Univ Pavia, Dept Drug Sci, Viale Taramelli 12, I-27100 Pavia, Italy
[2] PharmaExceed Srl, I-27100 Pavia, Italy
[3] Univ Appl Sci & Arts Southern Switzerland, Dept Innovat Technol, SUPSI, Via Pobiette 11, CH-6928 Manno, Switzerland
[4] Univ Pavia, Dept Clin Surg Diagnost & Pediat Sci, I-27100 Pavia, Italy
[5] Fdn IRCCS Policlin S Matteo, Immunol & Transplantat Lab, Pediat Surg Cell Factory & Regenerat Med Res Ctr, I-27100 Pavia, Italy
关键词
adipose tissue; bone marrow; exosome; extracellular vesicles; freeze-drying; immunomodulation; mesenchymal stromal cells; secretome; ultracentrifugation; ultrafiltration; EXTRACELLULAR VESICLES; STEM-CELLS; ULTRAFILTRATION; TISSUE; YIELD;
D O I
10.2217/nnm-2018-0240
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 [微生物学]; 090105 [作物生产系统与生态工程];
摘要
Aim: To validate the use of ultrafiltration (UF) as an alternative applicable industrial method to replace ultracentrifugation (UC) in the purification of mesenchymal stromal cell (MSC)-secretome. Materials & methods: Pharmaceutical formulations containing secretome and/or extracellular vesicles were extracted from adipose-MSCs and bone marrow-MSCs by combining UF or UC with lyophilization. Results & conclusion: UF led to higher protein, lipid, cytokine and exosomes yields compared with UC. The isolation procedure and cell source influenced immunomodulatory activity, which was in vitro evaluated by inhibition of phytohemagglutinin-activated peripheral blood mononuclear cell proliferation, and by modulation of IL-10, IFN-gamma and IL-6. A secretome dosage was identified to obtain the same immunomodulatory activity of MSCs, paving the way for cell-free therapy.
引用
收藏
页码:753 / 765
页数:13
相关论文
共 24 条
[1]
Challenges and Strategies for Improving the Regenerative Effects of Mesenchymal Stromal Cell-Based Therapies [J].
Baldari, Silvia ;
Di Rocco, Giuliana ;
Piccoli, Martina ;
Pozzobon, Michela ;
Muraca, Maurizio ;
Toietta, Gabriele .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (10)
[2]
Pilot Production of Mesenchymal Stem/Stromal Freeze-Dried Secretome for Cell-Free Regenerative Nanomedicine: A Validated GMP-Compliant Process [J].
Bari, Elia ;
Perteghella, Sara ;
Di Silvestre, Dario ;
Sorlini, Marzio ;
Catenacci, Laura ;
Sorrenti, Milena ;
Marrubini, Giorgio ;
Rossi, Rossana ;
Tripodo, Giuseppe ;
Mauri, Pierluigi ;
Marazzi, Mario ;
Torre, Maria Luisa .
CELLS, 2018, 7 (11)
[3]
Using exosomes, naturally-equipped nanocarriers, for drug delivery [J].
Batrakova, Elena V. ;
Kim, Myung Soo .
JOURNAL OF CONTROLLED RELEASE, 2015, 219 :396-405
[4]
Mesenchymal stem cells from human bone marrow or adipose tissue differently modulate mitogen-stimulated B-cell immunoglobulin production in vitro [J].
Bochev, Ivan ;
Elmadjian, Gabriel ;
Kyurkchiev, Dobroslav ;
Tzvetanov, Liubomir ;
Altankova, Iskra ;
Tivchev, Peter ;
Kyurkchiev, Stanimir .
CELL BIOLOGY INTERNATIONAL, 2008, 32 (04) :384-393
[5]
Interleukin-6 in Schizophrenia - Is There a Therapeutic Relevance? [J].
Borovcanin, Milica Milovan ;
Jovanovic, Ivan ;
Radosavljevic, Gordana ;
Pantic, Jelena ;
Janicijevic, Slavica Minic ;
Arsenijevic, Nebojsa ;
Lukic, Miodrag L. .
FRONTIERS IN PSYCHIATRY, 2017, 8
[6]
Ex vivo immunosuppressive effects of mesenchymal stem cells on Crohn's disease mucosal T cells are largely dependent on indoleamine 2,3-dioxygenase activity and cell-cell contact [J].
Ciccocioppo, Rachele ;
Cangemi, Giuseppina C. ;
Kruzliak, Peter ;
Gallia, Alessandra ;
Betti, Elena ;
Badulli, Carla ;
Martinetti, Miryam ;
Cervio, Marila ;
Pecci, Alessandro ;
Bozzi, Valeria ;
Dionigi, Paolo ;
Visai, Livia ;
Gurrado, Antonella ;
Alvisi, Costanza ;
Picone, Cristina ;
Monti, Manuela ;
Bernardo, Maria E. ;
Gobbi, Paolo ;
Corazza, Gino R. .
STEM CELL RESEARCH & THERAPY, 2015, 6
[7]
Mesenchymal stem/stromal cell extracellular vesicles: From active principle to next generation drug delivery system [J].
Crivelli, Barbara ;
Chlapanidas, Theodora ;
Perteghella, Sara ;
Lucarelli, Enrico ;
Pascucci, Luisa ;
Brini, Anna Teresa ;
Ferrero, Ivana ;
Marazzi, Mario ;
Pessina, Augusto ;
Torre, Maria Luisa .
JOURNAL OF CONTROLLED RELEASE, 2017, 262 :104-117
[8]
Mesenchymal Stem/Stromal Cells: A New "Cells as Drugs" Paradigm. Efficacy and Critical Aspects in Cell Therapy [J].
de Girolamo, Laura ;
Lucarelli, Enrico ;
Alessandri, Giulio ;
Avanzini, Maria Antonietta ;
Bernardo, Maria Ester ;
Biagi, Ettore ;
Brini, Anna Teresa ;
D'Amico, Giovanna ;
Fagioli, Franca ;
Ferrero, Ivana ;
Locatelli, Franco ;
Maccario, Rita ;
Marazzi, Mario ;
Parolini, Ornella ;
Pessina, Augusto ;
Torre, Maria Luisa .
CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (13) :2459-2473
[9]
Faustini M, 2010, TISSUE ENG PART C-ME, V16, P1515, DOI 10.1089/ten.TEC.2010.0214
[10]
The Immunoregulatory Activity of Mesenchymal Stem Cells: 'State of Art' and 'Future Avenues' [J].
Fierabracci, Alessandra ;
Del Fattore, Andrea ;
Muraca, Maurizio .
CURRENT MEDICINAL CHEMISTRY, 2016, 23 (27) :3014-3024